Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56101 - 56125 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	EOGT	285203	upregulated	panobinostat results in increased expression of EOGT mRNA	3p14.1	A21037
Panobinostat	Approved Investigational	EPAS1	2034	upregulated	panobinostat results in increased expression of EPAS1 mRNA	2p21	A21037
Panobinostat	Approved Investigational	EPB41L3	23136	upregulated	panobinostat results in increased expression of EPB41L3 mRNA	18p11.31	A21037
Panobinostat	Approved Investigational	EPB41L5	57669	upregulated	panobinostat results in increased expression of EPB41L5 mRNA	2q14.2	A21037
Panobinostat	Approved Investigational	EPCAM	4072	upregulated	panobinostat results in increased expression of EPCAM mRNA	2p21	A21037
Panobinostat	Approved Investigational	EPHA3	2042	upregulated	panobinostat results in increased expression of EPHA3 mRNA	3p11.1	A21037
Panobinostat	Approved Investigational	EPHA4	2043	downregulated	panobinostat results in decreased expression of EPHA4 mRNA	2q36.1	A21037
Panobinostat	Approved Investigational	EPHA7	2045	upregulated	panobinostat results in increased expression of EPHA7 mRNA	6q16.1	A21037
Panobinostat	Approved Investigational	EPHB2	2048	downregulated	panobinostat results in decreased expression of EPHB2 mRNA	1p36.12	A21037
Panobinostat	Approved Investigational	EPSTI1	94240	upregulated	panobinostat results in increased expression of EPSTI1 mRNA	13q14.11	A21037
Panobinostat	Approved Investigational	ERAP1	51752	downregulated	panobinostat results in decreased expression of ERAP1 mRNA	5q15	A21037
Panobinostat	Approved Investigational	ERBB3	2065	upregulated	panobinostat results in increased expression of ERBB3 mRNA	12q13.2	A21037
Panobinostat	Approved Investigational	ERP27	121506	upregulated	panobinostat results in increased expression of ERP27 mRNA	12p12.3	A21037
Panobinostat	Approved Investigational	ERVH-1	100616446	upregulated	panobinostat results in increased expression of ERVH-1 mRNA	4p15.2	A21037
Panobinostat	Approved Investigational	ERVH48-1	90625	upregulated	panobinostat results in increased expression of ERVH48-1 mRNA	21q22.3	A21037
Panobinostat	Approved Investigational	ERVMER61-1	339476	upregulated	panobinostat results in increased expression of ERVMER61-1 mRNA	1q31.1	A21037
Panobinostat	Approved Investigational	ESRG	790952	upregulated	panobinostat results in increased expression of ESRG mRNA	3p14.3	A21037
Panobinostat	Approved Investigational	ESRP1	54845	upregulated	panobinostat results in increased expression of ESRP1 mRNA	8q22.1	A21037
Panobinostat	Approved Investigational	ESRP2	80004	upregulated	panobinostat results in increased expression of ESRP2 mRNA	16q22.1	A21037
Panobinostat	Approved Investigational	ETNK1	55500	upregulated	panobinostat results in increased expression of ETNK1 mRNA	12p12.1	A21037
Panobinostat	Approved Investigational	ETS1	2113	upregulated	panobinostat results in increased expression of ETS1 mRNA	11q24.3	A21037
Panobinostat	Approved Investigational	ETV1	2115	downregulated	panobinostat results in decreased expression of ETV1 mRNA	7p21.2	A21037
Panobinostat	Approved Investigational	EXT1	2131	downregulated	panobinostat results in decreased expression of EXT1 mRNA	8q24.11	A21037
Panobinostat	Approved Investigational	EZR	7430	upregulated	panobinostat results in increased expression of EZR mRNA	6q25.3	A21037
Panobinostat	Approved Investigational	F2RL1	2150	upregulated	panobinostat results in increased expression of F2RL1 mRNA	5q13.3	A21037

Displaying entries 56101 - 56125 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability